Per-Patient Costs of Metastatic Prostate Cancer Estimated at $31,427
Increase in annual attributable costs observed over time, from $28,311 in 2007-2013 to $37,055 in 2014-2017.
Increase in annual attributable costs observed over time, from $28,311 in 2007-2013 to $37,055 in 2014-2017.
A search for financial assistance for those affected by breast cancer produced this list of organizations that provide up to 8 national and 4 regional grants.
Physicians are calling on colleagues to bring up the cost of care and its potential impact when discussing treatment options with patients.
Researchers analyzed data from Children’s Hospital of Philadelphia to determine the effects of poverty and neighborhood opportunity on outcomes of CAR-T therapy in young patients with R/R ALL or lymphoblastic lymphoma.
Higher risk also seen among patients experiencing increased urinary symptoms.
Researchers sought to determine how sequence of first- to third-line treatment of metastatic breast cancer influences cost and value of care.
Researchers examined how health insurance and financial literacy affect financial outcomes for patients with cancer.
Researchers sought to determine if offering financial reimbursement with or without a follow-up phone call would improve the diversity of patients participating in clinical trials.
Results of an analysis conducted via interviews with breast cancer survivors revealed the common areas of concern patients have regarding the costs of their care.
Systematic screening of patients’ electronic health record helped identify those patients at risk of financial toxicity.